Recall of A1C, blood pressure, and cholesterol levels among community pharmacy patients with diabetes

Journal of the American Pharmacists Association

Volumn 47, Issue 1, 2007, Pages 29-34

  Guirguis, Lisa M ^a   Kieser, Mara A ^b   Chewning, Betty A ^b   Kanous, Nathan L ^c  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c Physicians Plus Insurance Corporation   (United States)

Author keywords

Community and ambulatory pharmacy; Diabetes; Dyslipidemias; Hypertension; Risk factors (cardiovascular); Student pharmacists; Surveys

Indexed keywords

CHOLESTEROL; GLYCOSYLATED HEMOGLOBIN;

ARTICLE; BLOOD; BLOOD PRESSURE; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; HUMAN; PATHOPHYSIOLOGY; PATIENT; PHARMACY; PHYSIOLOGY; QUESTIONNAIRE; RECALL;

BLOOD PRESSURE; CHOLESTEROL; COMMUNITY PHARMACY SERVICES; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MENTAL RECALL; PATIENTS; QUESTIONNAIRES;

EID: 33947493990     PISSN: 15443191     EISSN: 15443450     Source Type: Journal    
DOI: 10.1331/1544-3191.47.1.29.Guirguis     Document Type: Article

References (28)

1. American Diabetes Association. All about diabetes. Accessed at www.diabetes.org/about-diabetes.jsp, February 16, 2006.
2. American Diabetes Association. Make the link! for health professionals. Accessed at www.diabetes.org/type-1-diabetes/well-being/link-healthprof.jsp, August 30, 2004.
3. American Diabetes Association. Cardiovascular disease risk in type 2 diabetes: can it be avoided? Accessed at www.prous.com/ada2004/article.asp?AID= 234, August 19, 2004.
4. Toth EL, Majumdar SR, Guirguis LM, et al. Compliance with clinical practice guidelines for type 2 diabetes in rural patients: treatment gaps and opportunities for improvement. Pharmacotherapy. 2003;23:659-65.
5. Saydah SH, Fradkin J, Cowie CC. Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA. 2004;291:335-42.
6. Clark NM. Management of chronic disease by patients. Annu Rev Public Health. 2003;24:289-313.
7. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulindependent diabetes mellitus. N Engl J Med. 1993;329:977-86.
8. Beckles GL, Engelgau MM, Narayan KM, et al. Population-based assessment of the level of care among adults with diabetes in the U.S. Diabetes Care. 1998;21:1432-8.
9. National Diabetes Education Program. Step 2: know your diabetes ABCs. Accessed at www.ndep.nih.gov/diabetes/control/4Steps.htm#Step2, August 30, 2004.
10. Beney J, Bero LA, Bond C. Expanding the roles of outpatient pharmacists: effects on health services utilisation, costs, and patient outcomes. Cochrane Database Syst Rev. 2000;(3):CD000336.
11. Cranor CW, Bunting BA, Christensen DB. The Asheville project: long-term clinical and economic outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc. 2003;43:173-84.
12. Cranor CW, Christensen DB. The Asheville project: short-term outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc. 2003;43:149-59.
13. Guirguis LM, Johnson JA. Diabetes: are pharmacists making an impact on patient outcomes? Can Pharm J. 2004;136:24-8.
14. Blenkinsopp A, Hassey A. Effectiveness and acceptability of community pharmacy-based interventions in type 2 diabetes: a critical review of intervention design, pharmacist and patient perspectives. Int J Pharm Pract. 2005;13:231-40.
15. Berringer R, Shibley MC, Cary CC, et al. Outcomes of a community pharmacy-based diabetes monitoring program. J Am Pharm Assoc. 1999;39:791-7.
16. American Diabetes Association. Standards of medical care for patients with diabetes mellitus. Diabetes Care. 2003;26(suppl 1):S33-S50.
17. Nash IS, Mosca L, Blumenthal RS, et al. Contemporary awareness and understanding of cholesterol as a risk factor: results of an American Heart Association national survey. Arch Intern Med. 2003;163:1597-600.
18. American Diabetes Association. Poor control of dyslipidemia in diabetes subjects. Accessed at www.prous.com/ada2004/article.asp?AID=212, August 19, 2004.
19. Grundy SM, Cleeman JI, Merz CN, et al. Implications of recent clinical trials for the national cholesterol education program adult treatment panel III guidelines. Circulation. 2004;110:227-39.
20. Osterweil N. Awareness of dyslipidemia in DM is high; but patients may be undertreated. Accessed at www.medscape.com/viewarticle/480290, August 19, 2004.
21. Tsuyuki RT, Johnson JA, Teo KK, et al. A randomized trial of the effect of community pharmacist intervention on cholesterol risk management: the study of cardiovascular risk intervention by pharmacists (SCRIP). Arch Intern Med. 2002;162:1149-55.
22. Mangum SA, Kraenow KR, Narducci WA. Identifying at-risk patients through community pharmacy-based hypertension and stroke prevention screening projects. J Am Pharm Assoc. 2003;43:50-5.
23. Snella KA, Roach AE, Irons BK, et al. Targeted community screening for diabetes and cardiovascular disease in community pharmacies and in non-healthcare settings. Paper presented at the 64th Annual Scientific Sessions of the American Diabetes Association, Orlando, 2004. Abstract 1206-P.
24. Schommer JC, Pedersen CA, Doucette WR, et al. Community pharmacists' work activities in the United States during 2000. J Am Pharm Assoc. 2002;42:399-406.
25. Svarstad BL, Bultman DC, Mount JK. Patient counseling provided in community pharmacies: effects of state regulation, pharmacist age, and busyness. J Am Pharm Assoc. 2004;44:22-9.
26. Chewning B. Patient involvement in pharmaceutical care: conceptual framework. Am J Pharm Educ. 1997;61:394-401.
27. Guirguis LM, Chewning BA. A pilot study on students' perceptions of patient interactions in community pharmacy and the importance of mattering. Paper presented at the International Conference on Communication in Healthcare, Chicago, 2005. Accessed at www.pcm.northwestern.edu/net-conf/poster-mid.htm, January 2, 2007. Abstract 353.
28. Walter LC, Davidowitz NP, Heineken PA, et al. Pitfalls of converting practice guidelines into quality measures: lessons learned from a VA performance measure. JAMA. 2004;291:2466-70.